Influence of Kinesio Taping on Muscle Activation, Muscle Strength and Performance of Young Football Athletes Jump

February 4, 2014 updated by: Daniela Ap. Biasotto-Gonzalez, University of Nove de Julho

INFLUENCE OF KINESIO TAPING ON MUSCLE ACTIVATION, MUSCLE STRENGTH AND PERFORMANCE JUMP IN YOUNG ATHLETES. CLINICAL STUDY, RANDOMIZED, PLACEBO-CONTROLLED AND DOUBLE BLIND

The objective of the project is to investigate the influence of application of Kinesio Taping in young athletes in football, muscle strength and muscle activation in the performance of the Single Leg Hop Test tests and Triple Hop Test methods: will be conducted a randomized, placebo-controlled and double-blind. 24 individuals will be athletes who fit the criteria for inclusion will be randomized into 2 groups (Placebo, Kinesio Taping Taping) and will be submitted to the tests of Single Leg Hop Test, Triple Hop Test, the isokinetic evaluation and electromyographic of Rectus Femoris dominant lower limb. Then the intervention shall be carried out with application of Kinesio Taping for activation of rectus femoris muscle group and placebo intervention Kinesio Taping with application of Kinesio Taping of transverse way the rectus femoris without tension in the Placebo group Taping. The volunteers will be re-evaluated 30 minutes after application of the technique and 12:0 am after with the same tests for that later can be compared the results obtained in each group. Analysis: will be achieved statistical tests and adopted a significance level of 5 percent

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Unknown

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The method of bandage with Kinesio Taping created by Kenzo Kase in 1996, it is the application of a thin, elastic tape with a thickness similar to the epidermis, on the skin. Being that it can be stretched up to 140 of its original length making it elastic enough compared to the conventional bandages. Kenzo still claims that the tape is able to reduce pain, swelling, muscle spasms and prevent injury. As much as there is today a widespread use of this technique mainly in the context of sports and orthopedics, still lack reliable studies to support the theory described by this method. Objectives: to investigate the influence of application of Kinesio Taping in young athletes in football, muscle strength and muscle activation in the performance of the Single Leg Hop Test tests and Triple Hop Test methods: will be conducted a randomized, placebo-controlled and double-blind. 24 individuals will be athletes who fit the criteria for inclusion will be randomized into 2 groups (Placebo, Kinesio Taping Taping) and will be submitted to the tests of Single Leg Hop Test, Triple Hop Test, the isokinetic evaluation and electromyographic of Rectus Femoris dominant lower limb. Then the intervention shall be carried out with application of Kinesio Taping for activation of rectus femoris muscle group and placebo intervention Kinesio Taping with application of Kinesio Taping of transverse way the rectus femoris without tension in the Placebo group Taping. The volunteers will be re-evaluated 30 minutes after application of the technique and 12:0 am after with the same tests for that later can be compared the results obtained in each group. Analysis: will be achieved statistical tests and adopted a significance level of 5 percent.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
24

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Brazil
      • São Paulo, Brazil, 01415000
        • Recruiting
        • University of Nove de Julho
        • Contact:
          • Daniela Biasotto Goonzalez, Doctor
          • Phone Number: +5511999063166
          • Email: dani_atm@ig.com.br

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

15 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Individuals aged between 15 and 20 years, Football players and Athletes who have body mass index (BMI) considered normal (between 20 and 25).

Exclusion Criteria:

  • History of lower limb musculoskeletal injuries in the last 6 months, history of lower limb and spine surgery in the last 6 months and BMI over 25 or less than 20.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Grupo A (Kinesio Taping)
Will be held the application of Kinesio Taping (Tex Gold) in the region of the rectus femoris dominant lower limb by a physical therapist trained in the technique (KT1 KT2 and) and with experience in this type of application to be designed without knowing in which group fits this patient. In the sequence, the athlete will be oriented to remain at rest for 30 min to get a better grip on the tape and one of the first tests and rest, only after this period will conduct a new evaluation of jump tests (single leg Hop test and Triple Hop Test) and, finally, a new test of strength in the isokinetic dinamomêtro in conjunction with the electromyographic assessment.
Procedure: Kinesio Taping
Application of Kinesio (Kinesio Tex Gold ®) of black color. The tape will be applied from proximal to distal, leaving the anterosuperior iliac spine Bottom, passing over the Rectus Femoris and ending in the region of the anterior tibia tuberosity with a voltage of 25 %.
Placebo Comparator: Placebo Taping
The volunteer will receive a Placebo application tape, being in this case the physical therapist will apply a strip of Kinesio Taping perpendicular to the muscle fibers of the rectus femoris of the dominant member of the individual.
Device: Kinesio Taping placebo
The volunteer who is allocated at random in the placebo group will receive an application of Kinesio transverse way the rectus femoris muscle, in order to verify a possible placebo effect of application of tape.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Hop Test
Time Frame: 1 year
The volunteer must position themselves in foot with unipodal support in the dominant lower limb behind a line that will be demarcated on the ground and jump as far as possible, without support in the contralateral limb or imbalance. The distance will be measured with a tape measure, from the starting point (line demarcated on the ground) until the most proximal point of the heel of the foot fell on the floor.
1 year

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Surface electromyography
Time Frame: 1 year
During isokinetic evaluation will also be carried out a study of the electrical activity of the rectus femoris muscle. For the capture of the electrical signal of that muscle will be used the acquisition system with 8 channels (EMG System of Brazil Ltda ®), composed of active electrodes with bipolar won 20 times amplification, analog filter pass band of 20 to 500 Hz and common mode rejection of 120 dB, and one of the channels will be enabled to use the force transducer (EMG System of Brazil Ltda ®). EMG signals are sampled with 2000 Hz frequency, scanned for AD conversion plate (analog-digital) with 16 bits of resolution.
1 year

Other Outcome Measures

Other Outcome Measures

For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Isokinetic evaluation of knee Extensors
Time Frame: 1 year
Immediately after heating and evaluation of jumps, the volunteers will perform the test of maximum voluntary contraction (CVM). Being they, positioned sitting on the seat of the isokinetic dynamometer (4, Biodex) the dominant limb is positioned to 60° of knee flexion (with 0° corresponds to total knee extension) and attached to the seat by means of a dynamometer belt. The non-dominant lower limb will also be positioned with 100° of flexion of hip and will also be attached to the seat with a belt. The volunteers will also be attached to the seat of the dynamometer through two belts across his torso. During the tests the volunteers will be instructed to place his arms across the trunk and the dynamometer axis is positioned parallel to the center of the knee joint. The CVM test will consist in the execution of three isometric contractions of knee extensors of the non-dominant lower limb with duration of 5 seconds, the highest torque value obtained in the three contractions (peak torque).
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Nove de Julho

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2014

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 1, 2014

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2014

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 4, 2014

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 4, 2014

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 6, 2014

Study Record Updates

Last Update Posted (Estimate)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 6, 2014

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 4, 2014

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2013

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 21892213.4.0000.5511

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings